Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases

Thrombosis Research

Volumn 107, Issue 5, 2002, Pages 223-228

  He, Meixia ^a   Wen, Zhibin ^a   He, Xiaofan ^a   Xiong, Shilong ^a   Liu, Fayi ^a   Xu, Jiangping ^a   Li, Juncheng ^a   Xie, Qinzhi ^a   Jian, Zaifu ^a   Chen, Fangping ^a   Xiao, Bo ^a   Pu, Xiaoqun ^a   He, Shilin ^a  

^a Central South University   (China)

Author keywords

Acute ischemic stroke; Acute myocardial infarction; Antithrombin III; Coagulation factors; Factor VII; Factor VIII; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY THROMBOSIS; HEART INFARCTION; METABOLISM; MIDDLE AGED; OCCLUSIVE CEREBROVASCULAR DISEASE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CORONARY THROMBOSIS; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOPLASTIN;

EID: 0036761807     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00331-6     Document Type: Article

References (31)

1. Sharrett A.R. The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. Ann. Epidemiol. 2:1992;467-469.
2. Cortellaro M., Boschetti C., Cofrancesco E., Zanussi C., Catalano M., de Gaetano G.et al. The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis. 90:1991;109-118.
3. Moss A.J., Goldstein R.E., Marder V.J., Sparks C.E., Oakes D., Greenberg H.et al. Thrombogenic factors and recurrent coronary events. Circulation. 99:1999;2517-2522.
4. Cote R., Wolfson C., Solymoss S., Mackey A., Leclerc J.R., Simard D.et al. Hemostatic markers in patients at risk of cerebral ischemia. Stroke. 31:2000;1856-1862.
5. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 96:1997;1102-1108.
6. Meade T.W., Cooper J., Miller G.J., Hoowarh D.J., Striling Y. Antithrombin III and arterial disease. Lancet. 338:1991;580-581.
7. Mann K.G., van't Veer C., Cawthern K., Butenas S. The role of the tissue factor pathway in initiation of coagulation. Blood Coagul. Fibrinolysis. 9(Suppl. 1):1998;S3-S7.
8. Sandset P.M., Bendz B., Hansen J.B. Physiological function of tissue factor pathway inhibitor and interaction with heparins. Haemostasis. 30(Suppl. 2):2000;48-56.
9. Falciani M., Gori A.M., Fedi S., Chiarugi L., Simonetti I., Dabizzi R.P.et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb. Haemost. 79:1998;495-499.
10. Freeburn J.C., Wallace J.M., Strain J.J., Sinnamon D.G., Craig B.M., Johnson D.et al. Monocyte tissue factor-like activity in post myocardial infarction patients. Br. J. Haematol. 102:1998;605-608.
11. Gillum R.F., Fortmann S.P., Prineas R.J., Kottke T.E. International diagnostic criteria for acute myocardial infarction and acute stroke. Am. Heart J. 108:1984;150-158.
12. Leng G.C., Lee A.J., Fowkes F.G., Whiteman M., Dunbar J., Housley E.et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 25:1996;1172-1181.
13. Fukuda C., Lijima K., Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin. Chem. 35:1989;1897-1900.
14. Sandset P.M., Larsen M.L., Abildgaard U., Lindahl A.K., Odegaard O.R. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul. Fibrinolysis. 2:1991;425-433.
15. He X., Wen Z., Xiong S., He M., Li J., He S. Studies on an assay for functional tissue factor pathway inhibitor antigen. Chin. J. Thromb. Hemostat. 7:2001;9-12.
16. Hitomi Y., Kanda T., Niinobe M., Fujii S. A sensitive colorimetric assay for thrombin, prothrombin and antithrombin III in human plasma using a new synthetic substrate. Clin. Chim. Acta. 119:1982;157-164.
17. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestinnung des Fibrinogens. Acta Haematol. 17:1957;237-246.
18. Chockley M., Penner J.A. An improved clinical assay for antithrombin III (heparin cofactor). Am. Clin. Pathol. 74:1980;213-217.
19. Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA, J. Am. Med. Assoc. 279:1998;1477-1482.
20. Ernst E., Hammerschmidt D.E., Bagge U., Matrai A., Dormandy J.A. Leukocytes and the risk of ischemic diseases. JAMA, J. Am. Med. Assoc. 257:1987;2318-2324.
21. Banner D.W. The factor VIIa/tissue factor complex. Thromb. Haemost. 78:1997;512-515.
22. Butenas S., van't Veer C., Mann K.G. "Normal" thrombin generation. Blood. 94:1999;2169-2178.
23. Rauch U., Osende J.I., Fuster V., Badimon J.J., Fayad Z., Chesebro J.H. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann. Intern. Med. 134:2001;224-238.
24. Camerer E., Kolsto A.B., Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb. Res. 81:1996;1-41.
25. Libby P., Sukhova G., Lee R.T., Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J. Cardiovasc. Pharmacol. 250160-2446:1995;S9-S12.
26. de Frutos T., Sanchez de Miguel L., Farre J., Gomez J., Romero J., Marcos-Alberca P.et al. Expression of an endothelial-type nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction. J. Am. Coll. Cardiol. 37:2001;800-807.
27. Kamikura Y., Wada H., Yamada A., Shimura M., Hiyoyama K., Shiku H.et al. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Am. J. Hematol. 55:1997;183-187.
28. Abumiya T., Yamaguchi T., Terasaki T., Kokawa T., Kario K., Kato H. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients. Thromb. Haemost. 74:1995;1050-1054.
29. Folsom A.R., Wu K.K., Davis C.E., Conlan M.G., Sorlie P.D., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
30. Takano K., Yamaguchi T., Okada Y., Uchida K., Kisiel W., Kato H. Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb. Res. 58:1990;481-491.
31. Saigo M., Abe S., Ogawa M., Biro S., Minagoe S., Maruyama I.et al. Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction. Thromb. Res. 100:2000;9-17.